Formuepleje A S Has $3.77 Million Holdings in Veralto Corporation $VLTO

Key Points

• Formuepleje A S increased its Veralto stake by 61.8% in the second quarter, bringing its holdings to 42,528 shares valued at approximately $3.77 million. Institutional investors collectively own 91.28% of the company.
• Veralto exceeded quarterly expectations, reporting $1.11 in EPS versus the $1.01 consensus estimate and $1.47 billion in revenue, up 7.5% year over year. The company guided for fiscal 2026 EPS of $4.35–$4.43.
• Analysts maintain a generally positive view, with six Buy ratings and four Holds producing a “Moderate Buy” consensus and an average price target of $110.90, compared with the stock’s reported $96.34 opening price.

Formuepleje A S boosted its holdings in shares of Veralto Corporation (NYSE:VLTO - Free Report) by 61.8% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 42,528 shares of the company's stock after purchasing an additional 16,240 shares during the period. Formuepleje A S's holdings in Veralto were worth $3,771,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Brighton Jones LLC grew its holdings in shares of Veralto by 16.1% during the fourth quarter. Brighton Jones LLC now owns 3,459 shares of the company's stock worth $352,000 after purchasing an additional 479 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Veralto by 5.3% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,947 shares of the company's stock valued at $2,529,000 after buying an additional 1,306 shares during the last quarter. Empowered Funds LLC lifted its position in Veralto by 20.4% during the 1st quarter. Empowered Funds LLC now owns 4,551 shares of the company's stock worth $443,000 after buying an additional 770 shares in the last quarter. Geneos Wealth Management Inc. lifted its position in Veralto by 102.4% during the 1st quarter. Geneos Wealth Management Inc. now owns 832 shares of the company's stock worth $81,000 after buying an additional 421 shares in the last quarter. Finally, Sivia Capital Partners LLC bought a new stake in Veralto during the 2nd quarter worth about $201,000. Institutional investors own 91.28% of the company's stock.

Insider Buying and Selling

In other Veralto news, SVP Surekha Trivedi sold 986 shares of the company's stock in a transaction on Monday, August 17th. The shares were sold at an average price of $97.05, for a total transaction of $95,691.30. Following the completion of the sale, the senior vice president owned 8,565 shares in the company, valued at approximately $831,233.25. The trade was a 10.32% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jennifer Honeycutt sold 7,097 shares of the stock in a transaction on Wednesday, July 29th. The shares were sold at an average price of $101.52, for a total value of $720,487.44. Following the completion of the transaction, the chief executive officer directly owned 124,085 shares in the company, valued at approximately $12,597,109.20. This trade represents a 5.41% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 15,180 shares of company stock worth $1,490,394. Insiders own 0.43% of the company's stock.

Veralto Stock Performance

Veralto stock opened at $96.34 on Monday. The company has a current ratio of 1.78, a quick ratio of 1.61 and a debt-to-equity ratio of 0.86. Veralto Corporation has a 1 year low of $80.03 and a 1 year high of $109.86. The company has a market cap of $23.49 billion, a PE ratio of 24.33, a PEG ratio of 2.73 and a beta of 0.60. The company's 50-day moving average is $95.22 and its two-hundred day moving average is $90.81.

Veralto (NYSE:VLTO - Get Free Report) last issued its quarterly earnings results on Tuesday, July 28th. The company reported $1.11 EPS for the quarter, topping the consensus estimate of $1.01 by $0.10. The company had revenue of $1.47 billion during the quarter, compared to analysts' expectations of $1.45 billion. Veralto had a net margin of 17.35% and a return on equity of 34.76%. Veralto's revenue was up 7.5% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.93 EPS. Veralto has set its FY 2026 guidance at 4.350-4.430 EPS and its Q3 2026 guidance at 1.060-1.090 EPS. Equities analysts anticipate that Veralto Corporation will post 4.41 earnings per share for the current year.

Wall Street Analysts Forecast Growth

VLTO has been the subject of several research reports. UBS Group raised their price objective on shares of Veralto from $98.00 to $104.00 and gave the company a "neutral" rating in a research report on Thursday, July 30th. Weiss Ratings reissued a "hold (c)" rating on shares of Veralto in a research note on Wednesday, June 24th. BNP Paribas Exane reissued an "outperform" rating and issued a $120.00 price target (up from $115.00) on shares of Veralto in a report on Thursday, July 30th. Citigroup boosted their price objective on shares of Veralto from $102.00 to $107.00 and gave the stock a "neutral" rating in a research report on Thursday, July 30th. Finally, Royal Bank Of Canada upped their price objective on Veralto from $100.00 to $109.00 and gave the stock a "sector perform" rating in a report on Thursday, July 30th. Six analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $110.90.

About Veralto

Veralto Corporation provides water analytics, water treatment, marking and coding, and packaging and color services worldwide. It operates through two segments, Water Quality (WQ) and Product Quality & Innovation (PQI). The WQ segment offers precision instrumentation and water treatment technologies to measure, analyze, and treat water in residential, commercial, municipal, industrial, research, and natural resource applications through the Hach, Trojan Technologies, and ChemTreat brands. This segment provides water solutions, including chemical reagents, services, and digital solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.